Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic [Phase 4]
Pilot Phase 4 trial evaluating treatment for hepatitis C at a psychiatrist-staffed outpatient addiction clinic completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Multi-center Study to Transplant Hepatitis-C Infected Kidneys [Phase 4]
A multi-center Phase 4 trial evaluated transplanting kidneys from hepatitis C-infected donors into recipients with renal failure, with resul…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL) [Phase 2]
Phase 2 clinical trial update for CDI-31244 in combination with Sofosbuvir and Velpatasvir in chronic hepatitis C has completed with results…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis [Phase 2, Phase 3]
A randomized placebo-controlled trial evaluating safety and efficacy of silymarin in acute viral hepatitis was terminated after Phase 2/3.
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection [Phase 2]
Phase 2 trial evaluating daclatasvir plus sofosbuvir in children with chronic hepatitis C was terminated; results were posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Directly Observed Therapy for HCV in Chennai, India [Phase 2]
Phase 2 clinical trial update on directly observed therapy for chronic hepatitis C in Chennai, India; completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Safety of Sofosbuvir in People With Advanced Kidney Failure [Phase 3]
A Phase 3 clinical trial update assessing the safety of Sofosbuvir in people with advanced kidney failure and chronic hepatitis C has comple…
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III [Phase 3]
Phase 3 trial update on danoprevir/r plus PR 12-week triple therapy in treatment-naive non-cirrhotic genotype 1 chronic hepatitis C showed c…
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers [NA]
A completed clinical trial assessing the interaction potential between dolutegravir and simeprevir in HIV/HCV seronegative volunteers.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation [Phase 4]
Phase 4 trial update on grazoprevir/elbasvir for genotype 1b chronic hepatitis C after liver or kidney transplantation; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant [Phase 4]
Phase 4 trial update evaluating antiviral therapy to prevent de novo hepatitis C infection after liver or kidney transplant; study completed…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients [Phase 1, Phase 2]
A phase 1/2 proof-of-concept study evaluating the safety and antiviral effect of BZF961 with or without ritonavir boosting in hepatitis C pa…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients [Phase 2]
Phase 2 trial evaluating TG-2349 in combination with DAG181 (± ribavirin) for efficacy and safety in hepatitis C genotype 1 non-cirrhotic pa…
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF) [Phase 4]
Phase 4 trial evaluating how Ledipasvir/Sofosbuvir affects the pharmacokinetics and renal safety of Tenofovir Alafenamide in patients with h…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C [Phase 2]
Phase 2 open-label trial of MBL-HCV1 with direct-acting antivirals in liver transplant patients with hepatitis C was terminated; results pos…
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients [Phase 3]
Phase III trial evaluating TG-2349 in combination with DAG181 and RBV for chronic hepatitis C virus genotype 1 patients in non-cirrhotic sta…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant [Phase 4]
Phase 4 trial update on sofosbuvir-based direct-acting antiviral therapy for HIV/HCV coinfected patients before or after liver transplant; s…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO [Phase 4]
Phase 4 real-world study assessing genotype 1 chronic hepatitis C treatment and real-world SVR and patient-reported outcomes.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Strategic Transformation of the Market of HCV Treatments [Phase 2, Phase 3]
A clinical trial update describing a strategic transformation in the market for hepatitis C treatments across Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C [NA]
Clinical trial update related to MK-MK-5172/MK-8742 aiming to increase treatment completion among veterans with active substance use disorde…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia [Phase 2, Phase 3]
Phase 2/3 trial update on an all-oral antiviral therapy for symptomatic hepatitis C virus–related cryoglobulinemia; study completed with res…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection [Phase 1]
Phase 1 study evaluating velpatasvir in chronic hepatitis C patients; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: Study of Oral Treatments for Hepatitis C [Phase 4]
A Phase 4 clinical trial update on oral treatments for chronic hepatitis C has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4 [Phase 3]
Phase 3 trial update evaluating eight weeks of elbasvir/grazoprevir for chronic hepatitis C genotype 4 has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment [Phase 1]
Phase 1 pharmacokinetics study evaluating velpatasvir in participants with normal renal function and severe renal impairment has completed.